22nd Century Group

$3.44
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.03 (+0.87%) As of 4:04 PM UTC today

Why Robinhood?

You can buy or sell XXII and other stocks, options, and ETFs commission-free!

About XXII

22nd Century Group Inc., also called 22nd Century Group, is a plant biotechnology company, which engages in the development of technology that will allow increasing or decreasing the level of nicotine and nicotinic alkaloids in tobacco plants and levels of cannabinoids in cannabis plants through genetic engineering and plant breeding. Its products include X-22, modified risk cigarettes, spectrum government research cigarettes, magic 0 and magic 2, moonlight, red sun, variable nicotine-level research cigarettes, and verfola. The company was founded on September 12, 2005 and is headquartered in Clarence, NY. The listed name for XXII is 22nd Century Group Inc.

CEO
James A Mish
Employees
67
Headquarters
Clarence, New York
Founded
2005
Market Cap
461.50M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
6.33M
High Today
$3.60
Low Today
$3.31
Open Price
$3.51
Volume
1.19M
52 Week High
$4.66
52 Week Low
$0.55

XXII Earnings

-$0.08
-$0.05
-$0.03
$0.00
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
— per share
Actual
Available Mar 11, Pre-Market

You May Also Like

RFAP
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure